Melanoma complicating treatment with natalizumab for multiple sclerosis

被引：83

作者：

Mullen, John T. ^{[1
]}

Vartanian, Timothy K. ^{[1
]}

Atkins, Michael B. ^{[1
]}

机构：

[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2008年 / 358卷 / 06期

关键词：

D O I：

10.1056/NEJMc0706103

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：647 / 648

页数：2

共 5 条

[1] Regulation of integrin activity by MIA [J].

Bauer, R ;

Humphries, M ;

Fässler, R ;

Winklmeier, A ;

Craig, SE ;

Bosserhoff, AK .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (17) :11669-11677

[2]

ISSEKUTZ TB, 1991, J IMMUNOL, V147, P109

[3] A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis [J].

Polman, CH ;

O'Connor, PW ;

Havrdova, E ;

Hutchinson, M ;

Kappos, L ;

Miller, DH ;

Phillips, JT ;

Lublin, FD ;

Giovannoni, G ;

Wajgt, A ;

Toal, M ;

Lynn, F ;

Panzara, MA ;

Sandrock, AW .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (09) :899-910

[4] EXPRESSION OF THE INTEGRIN ALPHA-4-BETA-1 ON MELANOMA-CELLS CAN INHIBIT THE INVASIVE STAGE OF METASTASIS FORMATION [J].

QIAN, F ;

VAUX, DL ;

WEISSMAN, IL .

CELL, 1994, 77 (03) :335-347

[5] Anti-alpha 4 integrin antibody induces apoptosis in murine thymocytes and staphylococcal enterotoxin B-activated lymph node T cells [J].

Tchilian, EZ ;

Owen, JJT ;

Jenkinson, EJ .

IMMUNOLOGY, 1997, 92 (03) :321-327

← 1 →